0.63%
8.20%
1.74%
19.09%
15.48%
-1.93%
33.51%
AI Spotlight on SOON
Company Description
Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children.It operates through two segments, Hearing Instruments and Cochlear Implants segments.The company offers wireless communication products; rechargeable hearing aids; wireless headsets, speech enhanced hearables, audiophile headphones, microphones, and wireless transmission systems; and audiological care services.
It also provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; consumer hearing products under the Sennheiser brand; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton brands.The company sells its products through independent distributors; and provides hearing care services through a network of approximately 3,600 stores and clinics.It operates in the United States, Europe, the Middle East, Africa, and the Asia Pacific.
The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007.Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Market Data
| Last Price | 320.7 |
| Change Percentage | 0.63% |
| Open | 319.7 |
| Previous Close | 318.7 |
| Market Cap ( Millions) | 19113 |
| Volume | 57000 |
| Year High | 337.2 |
| Year Low | 244.1 |
| M A 50 | 301.78 |
| M A 200 | 292.31 |
Financial Ratios
| FCF Yield | 3.47% |
| Dividend Yield | 1.34% |
| ROE | 26.24% |
| Debt / Equity | 72.64% |
| Net Debt / EBIDTA | 153.16% |
| Price To Book | 7.73 |
| Price Earnings Ratio | 31.79 |
| Price To FCF | 28.79 |
| Price To sales | 5.27 |
| EV / EBITDA | 24.37 |
News
- Jan -30 - Hearing-Aid Maker Transforms Into Unlikely AI Stock Winner
- Jan -30 - Swiss Hearing-Aid Maker Transforms Into Unlikely AI Stock Winner
- Jan -22 - IART vs. SONVY: Which Stock Is the Better Value Option?
- Nov -20 - Sonova Holding AG (SONVF) (H1 2025) Earnings Call Highlights: Navigating Growth Amidst Market ...
- Nov -19 - Launch costs hit Sonova's profit, as it bets on new product with AI tech
- Aug -06 - Sonova launches first real-time AI hearing aid
- Aug -06 - Sonova launches hearing aid with real-time AI, first in market
- Aug -06 - Sonova launches hearing aid with real-time AI, first in market
- Jul -10 - GMED vs. SONVY: Which Stock Is the Better Value Option?
- Jul -09 - TFX vs. SONVY: Which Stock Is the Better Value Option?
- May -14 - UPDATE 1-European shares limp ahead of US data, Powell remarks; Delivery Hero spikes
- May -10 - Stocks to watch this week: Burberry, Vodafone, BT and Walmart
- Apr -26 - Stocks to watch this week: Amazon, Apple, Anglo American and Novo Nordisk
- Apr -23 - Trending tickers: Tesla, ABF, Novartis, Taylor Wimpey, JD Sports
- Apr -09 - Those who invested in Geberit (VTX:GEBN) five years ago are up 39%
- Apr -03 - Retail investors account for 48% of Sonova Holding AG's (VTX:SOON) ownership, while institutions account for 35%
- Feb -29 - Under The Bonnet, BELIMO Holding's (VTX:BEAN) Returns Look Impressive
- Feb -26 - Are Strong Financial Prospects The Force That Is Driving The Momentum In Sonova Holding AG's VTX:SOON) Stock?
- Feb -08 - HOLX vs. SONVY: Which Stock Is the Better Value Option?
- Jan -19 - Compagnie Financière Tradition (VTX:CFT) shareholders have earned a 9.6% CAGR over the last five years
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Hearing Instruments
Expected Growth : 8.37 %
What the company do ?
Hearing Instruments from Sonova Holding AG refers to advanced hearing aids and cochlear implants designed to improve speech understanding and sound quality for individuals with hearing loss.
Why we expect these perspectives ?
Sonova Holding AG's 8.37% growth in Hearing Instruments is driven by increasing demand for hearing aids, particularly in emerging markets, and the company's strong brand portfolio, including Phonak and Unitron. Additionally, advancements in technology, such as rechargeable batteries and artificial intelligence, are enhancing product offerings and driving sales.
Segment n°2 -> Cochlear Implants
Expected Growth : 8.37 %
What the company do ?
Cochlear Implants from Sonova Holding AG are medical devices that bypass damaged hair cells in the ear, directly stimulating the auditory nerve to restore hearing in individuals with severe to profound sensorineural hearing loss or single-sided deafness.
Why we expect these perspectives ?
Strong demand for Cochlear Implants from Sonova Holding AG, driven by increasing prevalence of hearing loss, advancements in technology, and expanding access to healthcare in emerging markets. Additionally, growing awareness and adoption of cochlear implants among pediatric and adult populations, as well as strategic partnerships and investments in research and development, contribute to the 8.37% growth.
Sonova Holding Ag Products
| Product Range | What is it ? |
|---|---|
| Hearing Aids | Sonova's hearing aids are designed to improve communication and quality of life for individuals with hearing loss. They offer a range of styles, from discreet and invisible to stylish and sleek. |
| Cochlear Implants | Sonova's cochlear implants are designed to restore hearing for individuals with severe to profound sensorineural hearing loss. They bypass damaged hair cells in the ear and directly stimulate the auditory nerve. |
| Bone Conduction Implants | Sonova's bone conduction implants are designed to restore hearing for individuals with conductive hearing loss, single-sided deafness, or mixed hearing loss. They use the skull to transmit sound waves to the inner ear. |
| Wireless Accessories | Sonova's wireless accessories, such as remote controls and streamers, enable seamless connectivity between hearing aids and other devices, enhancing the listening experience. |
| Auditory Diagnostics | Sonova's auditory diagnostics solutions are designed to identify and diagnose hearing loss, providing accurate and reliable results for healthcare professionals. |
Sonova Holding AG's Porter Forces
Threat Of Substitutes
The threat of substitutes for Sonova Holding AG is medium, as there are alternative products available in the market, but they are not highly attractive to customers.
Bargaining Power Of Customers
The bargaining power of customers for Sonova Holding AG is low, as customers have limited options and the company has a strong brand presence.
Bargaining Power Of Suppliers
The bargaining power of suppliers for Sonova Holding AG is medium, as the company relies on a few key suppliers, but has some flexibility in its supply chain.
Threat Of New Entrants
The threat of new entrants for Sonova Holding AG is low, as the company has a strong brand presence and high barriers to entry in the hearing aid industry.
Intensity Of Rivalry
The intensity of rivalry for Sonova Holding AG is high, as the company operates in a highly competitive market with several established players.
Strength
Capital Structure
| Value | |
|---|---|
| Debt Weight | 39.16% |
| Debt Cost | 3.95% |
| Equity Weight | 60.84% |
| Equity Cost | 8.80% |
| WACC | 6.90% |
| Leverage | 64.35% |
Sonova Holding AG : Quality Control
Sonova Holding AG passed 5 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| PHIA.AS | Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The … |
| SNT.WA | Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and … |
| NOVO-B.CO | Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. … |
| GSK.L | GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the … |
| STE | STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
GSK
A-Score
1-Year Total Return ->
🥈
Sonova
A-Score
1-Year Total Return ->
🥉
Novo Nordisk
A-Score
1-Year Total Return ->
4
Synektik
A-Score
1-Year Total Return ->
5
STERIS
A-Score
1-Year Total Return ->
6
